Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS variant
/PRNewswire/ -- Intravacc, a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines and the German...
Source: prnewswire.com